Inspira Technologies Oxy B H N Ltd (IINN) Return on Assets ROA from the fourth quarter of 2024 to fourth quarter of 2022 and for the year 2024, Average High and Low, Fundamental Ratios from Dec 31 2024 to Dec 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Inspira Technologies Oxy B H N Ltd  (NASDAQ: IINN)


Inspira Technologies Oxy B H N Ltd's ROA from the fourth quarter of 2024 to the fourth quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Inspira Technologies Oxy B H N Ltd's ROA in the fourth quarter of 2024?
Inspira Technologies Oxy B H N Ltd achieved a return on average assets (ROA) of 81.73 % in its fourth quarter of 2024, this is above IINN's average return on assets of -81.1%.
Inspira Technologies Oxy B H N Ltd assets over the 12 months ending in its fourth quarter of 2024 are valued at $14 million

ROA has improved compared to 0% in the third quarter of 2024, due to net income growth.

However, within the Healthcare sector 1035 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2024 from to 44.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2024)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Total Assets Change 43.98 % -44.83 % 1.43 % 108.31 % -69.37 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million 11 0 0 0 0
Return On Assets (TTM) 81.73 % 0 % 0 % 0 % 0 %
IINN's Total Ranking # 44 # # # # 5553
Total Assets (TTM) in million 19 4 23 8 13
Seq. Total Assets Change 322.46 % -80.45 % 182.13 % -38.22 % 61.87 %
Seq. Net Income Change - - - - -

IINN's 5 Years Annual ROA >> Back to IINN Management Effectiveness >> Compare IINN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 221
Sector # 1036
Overall # 5442

Return On Assets Statistics
High Average Low
136.96 %
-81.1 %
-247.52 %
(Dec 31 2024)   (Dec 31 2025)



  News about Inspira Technologies Oxy B H N Ltd Return on Assets ROA

Inspira Technologies In Government Talks to Boost ART100 Integration and Global Reach

Inspira Technologies Eyes Strategic Growth through Government Talks and Strong Financial Performance Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN), based in Ra anana, Israel, is making significant moves as it engages in high-level discussions with a major government health authority, aiming to solidify the integration of its ART100 system as a key asset in national emergency infrastructure. This strategic dialogue marks a critical step for the company, reinforcing its pioneering role in life-support and diagnostic technologies. The talks are not only focused on national integration but also hold promising prospects for establishing a global distribution framework for the ART100.The ART100 system, which has already received clearance from the U.S. Food and Drug Administration (FDA), is envisioned to become a foundational element within the emergency response measures of the partnering nation. Although details of the discussions remain confidential, the potential agreement is expected to bolster Inspira s stature on both national and international fronts, providing an exemplary showcase of public-private collaboration in enhancing healthcare capabilities.



Financial Statements
Inspira Technologies Oxy B H N Ltd's Assets $ 19 million IINN's Balance sheet
Inspira Technologies Oxy B H N Ltd's Income $ 11 million Quarterly IINN's Income Statement
IINN's Income by Division See IINN's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change -17.36 % 1.43 % -44.32 % 56.85 % -
Total Assets in million 19 23 22 40 26
Y / Y Net Income Change - - - - -
Net Income in million -13 11 -11 -15 -17
Annual Return On Assets -70.26 % 48.55 % -50.28 % -37.15 % -66.89 %

IINN's 5 Years Annual ROA >> Back to IINN Management Effectiveness >> Compare IINN ROA to its Competitors



More Return On Assets Ratios
IINN's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IINN's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IINN's Competitors
Subscribers only: Roa for Inspira Technologies Oxy B H N Ltd's Suppliers
Subscribers only: Return On Assets for IINN's Customers

You may also want to know
IINN's Roi IINN's Inventory Turnover Ratio IINN's Growth Rates IINN's Dividend Comparisons
IINN's Profitability Ratios IINN's Asset Turnover Ratio IINN's Dividend Growth
IINN's Roe IINN's Valuation Ratios IINN's Financial Strength Ratios IINN's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2024, within Healthcare Sector ROA
Capforce Inc   214.54 %
Orgenesis Inc   211.87 %
AnTix Holdings, Inc.  194.68 %
Camp4 Therapeutics Corporation  146.34 %
Inspira Technologies Oxy B H N Ltd  136.96 %
Alumis inc   124.51 %
Polypid Ltd  115.08 %
Pavmed Inc   82.47 %
Oak Woods Acquisition Corp  80.22 %
Addex Therapeutics Ltd  66.08 %
Longduoduo Co Ltd  62.80 %
Tao Synergies Inc   58.36 %
Sbc Medical Group Holdings Incorporated  56.18 %
Agios Pharmaceuticals Inc   53.07 %
Earth Science Tech Inc   52.61 %
Interpace Biosciences Inc   51.47 %
Gridai Technologies Corp  51.03 %
Adma Biologics Inc   49.22 %
Protagonist Therapeutics inc   42.46 %
Exelixis Inc   41.90 %
Galmed Pharmaceuticals Ltd   40.54 %
Semnur Pharmaceuticals Inc   36.42 %
Edwards Lifesciences Corporation  36.37 %
Dariohealth Corp   35.04 %
Semler Scientific inc   32.68 %
Pharmacyte Biotech Inc   29.33 %
Biomx Inc  27.98 %
Siga Technologies Inc  27.05 %
Idexx Laboratories Inc  26.48 %
Mettler toledo International Inc   26.37 %

Date modified: 2026-09-02T17:55:35+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.